Transplant Diagnostics Market

Transplant Diagnostics Market (Product & Service: Instruments, Kits and Reagents and Software and Services; Technique: Molecular Assay and Non-molecular Assay; and Transplant Type: Organ Transplant, Tissue Transplant and Stem Cell Transplant) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

Transplant Diagnostics Market Outlook 2035

  • The global industry was valued at US$ 7.8 Bn in 2024
  • It is projected to grow at a CAGR of 7.3% from 2025 to 2035 and cross US$ 17.2 Bn by the end of 2035

Analysts’ Viewpoint

Surging volume of organ transplantation procedures, technological advancements in molecular diagnostics, genetic testing, identification of biomarkers, awareness among masses regarding the requirement for organ transplantation and supportive policies and regulations made by the government are some of the key trends bound to propel the transplant diagnostics market size. The demographic shift toward aging population is also necessitating the availability of efficient diagnostic tools to make organ matching in transplantation possible.

Transplant Diagnostics Market Revenue Growth

In line with the latest transplant diagnostics market trends, the industry is currently experiencing significant transformation, characterized by advancements in technology and an increasing emphasis on personalized medicine. Emerging technologies such as next-generation sequencing and molecular profiling are increasing the donor-recipient matching and accuracy of transplant success.

Machine learning and artificial intelligence are being used in diagnostics, which is improving workflows and data analysis. These trends render such increasing interest in optimizing patient benefit and consolidating the profession of transplant medicine relevant. Mergers and collaborations between top players of the industry is helping drive the pace for innovation as well as gain more market space, particularly in emerging economies.

Market Introduction

Transplant diagnostics consists of a collection of medical testing techniques employed for assessing organ donor-recipient compatibility with the view of obtaining successful transplantation. Transplant diagnostics are useful in identifying potential immunological incompatibility as well as likelihood of transplant rejection.

One of the significant uses of transplant diagnostics is organ transplantation, where diagnosis tests confirm that the patient undergoing the organ is most compatible to a donor organ. For example, human leukocyte antigen (HLA) typing is a routine diagnosis test, which is aimed at identifying specific proteins that are present in cell membranes and primarily accountable for immunity.

By matching the donor and recipient based on their HLA types, physicians can prevent organ rejection to a significant extent. Additionally, in order to evaluate the transplant health of the recipient, non-invasive diagnostics such as circulating cell-free DNA (cfDNA) tests are employed for the quantification of donor-derived DNA in the recipient's blood.

Attribute Details
Market Drivers
  • Rising Incidence of Organ Transplants
  • Increasing Awareness and Acceptance of Organ Donation

Rising Incidence of Organ Transplants Anticipated to Boost Transplant Diagnostics Market Share

The growth rate of organ transplants has contributed drastically to transplant diagnostics market growth. With continuously increasing demand for organ transplantation due to demographics like aging population, increased incidence of chronic disease, and availability of advanced medical technology, the need for proper diagnostic machinery has also become increasingly significant. Transplant diagnostics has a significant role to play in organ transplant success by identifying donor and recipient compatibility, tracking the health of organs, and avoiding rejection.

While global statistics account for consistent increase in organ transplant procedures, physicians are increasingly relying on advanced diagnostic equipment to yield improved patient outcomes. Advances in the form of genetic screening, molecular diagnostics, and advanced imaging technology are being utilized to offer more precise predictions regarding organ compatibility and function.

Transplant Diagnostics Market Share By Product And Service 2024

Further, statistics from the Organ Procurement and Transplantation Network (OPTN) reveal that 48,149 organ transplants were reported in the U.S. in 2024. This represents a 3.3% increase in the number of transplantations as compared to 2023, and 23.3% rise over the past five years.

Expanding number of transplant programs across different geographies, specifically in developing countries, are also fueling the market's growth. The growing awareness regarding organ donation and transplantation, alongside public health initiatives, is instilling confidence within people to consider organ donation and subsequently boosting the pool of donors. The transplant diagnostic market therefore is witnessing a growth in investment made by both government and private firms, leading to enhancements in research and development activities.

Increasing Awareness and Acceptance of Organ Donation to Drive Market Expansion

One of the key driving forces in the transplant diagnostics market is growing awareness and the trend toward organ donation. The donor pool is increased as increasing numbers of people become aware of the life-saving potential of organ transplantation and are thus willing to sign up to become donors.

Institutions such as health organizations, non-profit organizations, and government organizations have been quite effective in campaigns regarding the significance of organ donation and dispelling common myths that people have associated with organ donation. This increased sensitivity not only provokes increased enrollments but also sparks a cultural transition to regard organ donation as a valuable component of civic responsibility.

With increasingly available donors, there comes the demand for advanced transplant diagnostics. Transplant diagnostics are required to match donors and recipients, assess the viability of organs, and monitor the success of transplants. Genomic analysis technologies, biomarker identification, and immunological profiling are increasingly important in a bid to deliver the best transplant outcomes.

Furthermore, the convergence of digital health technologies and social networking sites has enabled awareness campaigns regarding organ donation information to reach its widest audience to date. Beyond education of the masses, it encourages real-time discussion and personal accounts by recipients of transplants and donor families, thereby raising the positive impacts of donation.

Kits and Reagents Leading the Global Transplant Diagnostics Market

The kits and reagents category dominates the transplant diagnostics market due to the central role such products play in facilitating effective donor-recipient matching. These products allow physicians to carry out necessary tests, including genetic tests and immunologic tests, necessary in prevention of organ rejection and facilitating maximum transplant success.

Their extensive application in hospitals and laboratories, in combination with advancements in technology that enhance the sensitivity and speed of tests, creates high demand. Additionally, the growing rate of organ transplants globally keeps driving demand for the diagnostic kits and reagents, rendering them the crux of transplant surgeries.

Molecular Assay Hold Majority Market Share in the Global Transplant Diagnostics Industry

Molecular assay segment of the transplant diagnostics market holds the major share owing to its ability to provide highly sensitive and specific results for donor-recipient compatibility testing.

Molecular tests are important in the identification of infectious agents and potential rejection risks because they analyze DNA, RNA, and proteins. The use of molecular assays has risen with the increased application of newer molecular methods such as next-generation sequencing (NGS) and polymerase chain reaction (PCR). Molecular assay market is also expected to continue driving market growth as the transplant process advances and becomes more individualized.

Regional Outlook of Transplant Diagnostics Market

Attribute Detail
Leading Region North America

As per the latest transplant diagnostics market report, North America dominated with the highest share in 2024. This can be ascribed to the region's superior healthcare infrastructure, a high level of investment in research and development, leading to innovative diagnostic technologies. The demand for organ transplant is being fueled by the rising prevalence of chronic diseases in the region, such as diabetes and kidney failure, which in turn is fueling demand for efficient diagnostic technology.

Transplant Diagnostics Market Share By Region 2024

The U.S. dominates the market for transplant diagnostics in North America owing to the country's highly advanced healthcare infrastructure and a high level of research investment in the medical sector. A strong presence of top diagnostic companies and advanced technologies has established the U.S. at the top of transplant diagnostics.

In addition, stringent regulatory guidelines and large transplant networks promise to embrace advanced diagnostic solutions. The focus on delivering the highest possible patient care through tailored medicine and continuous innovation in laboratory techniques further strengthen the U.S. leadership position in North America's transplant diagnostics market .

Analysis of Key Players in Transplant Diagnostics Market

Key players in the transplant diagnostics industry are forming strategic collaborations to conduct targeted research initiatives. Furthermore, companies are expanding their operations to developing nations, where the volume of transplant procedures is expected to increase remarkably in the coming years. These initiatives are playing a crucial role in fostering innovation and driving market expansion.

Abbott, Bio-Rad Laboratories, Inc., QIAGEN N.V., Bruker Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, QuidelOrtho Corporation, bioMérieux, Illumina, Inc., Siemens Healthineers, Agilent Technologies, Inc., Takara Bio Inc., Hologic, Inc., Werfen, S.A., and DiaSorin S.p.A. are some of the leading key players operating in the global transplant diagnostics market.

Each of these players have been have been profiled in the transplant diagnostics market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments

  • In October 2024, QIAGEN announced key updates to its sample technologies solution, EZ2 Connect platform, for non-invasive liquid biopsy applications for use in research and clinical applications such as oncology, prenatal care, and organ transplantation. The EZ1&2 ccfDNA Kit has been upgraded to support fully automatic simultaneous processing of a maximum number of 24 samples of 10 ml serum or plasma and a new provided urine protocol. The company also introduced QIAsymphony DSP Circulating DNA Kit (96) and the QIAsymphony DSP Circulating DNA Maxi Kit (192), automated systems specifically designed for the isolation of ccfDNA from a maximum volume of 10ml.
  • In July 2024, Thermo Fisher Scientific released a new pre-transplant risk assessment assay from its CLIA laboratory in Fishers, Ind. The newly launched assay quantifies risk of early acute rejection in kidney transplant recipients and presents data that could be used to inform a more individualized post-transplant immunosuppression regimen.

Transplant Diagnostics Market Snapshot

Attribute Details
Size in 2024 US$ 7.8 Bn
Forecast Value in 2035 US$ 17.2 Bn
CAGR 7.3%
Forecast Period 2025-2035
Historical Data Available for 2020-2024
Quantitative Units US$ Bn
Transplant Diagnostics Market Analysis It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis.
Competition Landscape
  • Competition Matrix
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Segmentation
  • Product & Service
    • Instruments
    • Kits and Reagents
    • Software and Services
  • Technique
    • Molecular Assay
    • Non-molecular Assay
  • Transplant Type
    • Organ Transplant
      • Kidney
      • Liver
      • Heart
      • Lung
      • Others
    • Tissue Transplant
      • Corneal Transplant
      • Skin Transplant
      • Bone Transplant/Bone Graft
      • Cartilage Transplants
      • Others
    • Stem Cell Transplant
  • Screening Type
    • Pre-Transplant Diagnostics
    • Post-Transplant Diagnostics
  • End-user
    • Hospitals
    • Transplant Centers
    • Research Laboratories
    • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • Australia & New Zealand
  • India
  • Japan
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa
Companies Profiled
  • Abbott
  • Bio-Rad Laboratories, Inc.
  • QIAGEN N.V.
  • Bruker Corporation
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson and Company
  • QuidelOrtho Corporation
  • bioMérieux
  • Illumina, Inc.
  • Siemens Healthineers
  • Agilent Technologies, Inc.
  • Takara Bio Inc.
  • Hologic, Inc.
  • Werfen, S.A.
  • DiaSorin S.p.A.
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global transplant diagnostics market in 2024?

The global transplant diagnostics market was valued at US$ 7.8 Bn in 2024.

How big will the transplant diagnostics business be in 2035?

The global transplant diagnostics business is projected to reach more than US$ 17.2 Bn by the end of 2035.

What are the factors driving the transplant diagnostics market?

Rising incidence of organ transplants and technological innovations in diagnostic technologies.

What will be the CAGR of the global transplant diagnostics industry during the forecast period?

The CAGR is anticipated to be 7.3% from 2025 to 2035.

Who are the prominent players in the global transplant diagnostics market?

Abbott, Bio-Rad Laboratories, Inc., QIAGEN N.V., Bruker Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, QuidelOrtho Corporation, bioMérieux, Illumina, Inc., Siemens Healthineers, Agilent Technologies, Inc., Takara Bio Inc., Hologic, Inc., Werfen, S.A. and DiaSorin S.p.A. are the prominent players in the transplant diagnostics market.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Transplant Diagnostics Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Transplant Diagnostics Market Analysis and Forecast, 2017 to 2031

5. Key Insights

    5.1. Pipeline Analysis

    5.2. Key Product/Brand Analysis

    5.3. Key Mergers & Acquisitions

    5.4. COVID-19 Pandemic Impact on Industry

6. Global Transplant Diagnostics Market Analysis and Forecast, by Screening

    6.1. Introduction and Definitions

    6.2. Key Findings/Developments

    6.3. Market Value Forecast, by Screening, 2017 to 2031

        6.3.1. Pre-transplant Diagnostics

        6.3.2. Post-transplant Diagnostics

    6.4. Market Attractiveness, by Screening

7. Global Transplant Diagnostics Market Analysis and Forecast, by Technique

    7.1. Introduction and Definitions

    7.2. Key Findings/Developments

    7.3. Market Value Forecast, by Technique, 2017 to 2031

        7.3.1. Molecular Assay

        7.3.2. Non-molecular Assay

        7.3.3. 7.4 Market Attractiveness, by Technique

8. Global Transplant Diagnostics Market Analysis and Forecast, by Application

    8.1. Introduction and Definitions

    8.2. Key Findings/Developments

    8.3. Market Value Forecast, by Application, 2017 to 2031

        8.3.1. Solid Organ Transplantation

            8.3.1.1. Kidney

            8.3.1.2. Liver

            8.3.1.3. Heart

            8.3.1.4. Lungs

            8.3.1.5. Pancreas

            8.3.1.6. Small Bowel

        8.3.2. Stem Cell Transplantation

    8.4. Market Attractiveness, by Application

9. Global Transplant Diagnostics Market Analysis and Forecast, by Products & Services

    9.1. Introduction and Definitions

    9.2. Key Findings/Developments

    9.3. Market Value Forecast, by Products & Services, 2017 to 2031

        9.3.1. Reagents & Consumables

        9.3.2. Instruments

        9.3.3. Software & Services

    9.4. Market Attractiveness, by Products & Services

10. Global Transplant Diagnostics Market Analysis and Forecast, by End-user

    10.1. Introduction and Definitions

    10.2. Key Findings/Developments

    10.3. Market Value Forecast, by End-user, 2017 to 2031

        10.3.1. Hospitals & Transplant Centers

        10.3.2. Research Laboratories

        10.3.3. Others

    10.4. Market Attractiveness, by End-user

11. Global Transplant Diagnostics Market Analysis and Forecast, by Region

    11.1. Key Findings

    11.2. Market Value Forecast, by Region, 2017 to 2031

        11.2.1. North America

        11.2.2. Europe

        11.2.3. Asia Pacific

        11.2.4. Latin America

        11.2.5. Middle East & Africa

    11.3. Market Attractiveness, by Region

12. North America Transplant Diagnostics Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Screening, 2017 to 2031

        12.2.1. Pre-transplant Diagnostics

        12.2.2. Post-transplant Diagnostics

    12.3. Market Attractiveness, by Screening

    12.4. Market Value Forecast, by Technique, 2017 to 2031

        12.4.1. Molecular Assay

        12.4.2. Non-molecular Assay

    12.5. Market Attractiveness, by Technique

    12.6. Market Value Forecast, by Application, 2017 to 2031

        12.6.1. Solid Organ Transplantation

            12.6.1.1. Kidney

            12.6.1.2. Liver

            12.6.1.3. Heart

            12.6.1.4. Lungs

            12.6.1.5. Pancreas

            12.6.1.6. Small Bowel

        12.6.2. Stem Cell Transplantation

    12.7. Market Attractiveness, by Application

    12.8. Market Value Forecast, by Products & Services, 2017 to 2031

        12.8.1. Reagents & Consumables

        12.8.2. Instruments

        12.8.3. Software & Services

    12.9. Market Attractiveness, by Products & Services

    12.10. Market Value Forecast, by End-user, 2017 to 2031

        12.10.1. Hospitals & Transplant Centers

        12.10.2. Research Laboratories

        12.10.3. Others

    12.11. Market Attractiveness, by End-user

    12.12. Market Value Forecast, by Country/Sub-region, 2017 to 2031

        12.12.1. U.S.

        12.12.2. Canada

    12.13. Market Attractiveness Analysis

        12.13.1. By Screening

        12.13.2. By Technique

        12.13.3. By Application

        12.13.4. By Products & Services

        12.13.5. By End-user

        12.13.6. By Country

13. Europe Transplant Diagnostics Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Screening, 2017 to 2031

        13.2.1. Pre-transplant Diagnostics

        13.2.2. Post-transplant Diagnostics

    13.3. Market Attractiveness, by Screening

    13.4. Market Value Forecast, by Technique, 2017 to 2031

        13.4.1. Molecular Assay

        13.4.2. Non-molecular Assay

    13.5. Market Attractiveness, by Technique

    13.6. Market Value Forecast, by Application, 2017 to 2031

        13.6.1. Solid Organ Transplantation

            13.6.1.1. Kidney

            13.6.1.2. Liver

            13.6.1.3. Heart

            13.6.1.4. Lungs

            13.6.1.5. Pancreas

            13.6.1.6. Small Bowel

        13.6.2. Stem Cell Transplantation

    13.7. Market Attractiveness, by Application

    13.8. Market Value Forecast, by Products & Services, 2017 to 2031

        13.8.1. Reagents & Consumables

        13.8.2. Instruments

        13.8.3. Software & Services

    13.9. Market Attractiveness, by Products & Services

    13.10. Market Value Forecast, by End-user, 2017 to 2031

        13.10.1. Hospitals & Transplant Centers

        13.10.2. Research Laboratories

        13.10.3. Others

    13.11. Market Attractiveness, by End-user

    13.12. Market Value Forecast, by Country/Sub-region, 2017 to 2031

        13.12.1. Germany

        13.12.2. U.K.

        13.12.3. France

        13.12.4. Italy

        13.12.5. Spain

        13.12.6. Rest of Europe

    13.13. Market Attractiveness Analysis

        13.13.1. By Screening

        13.13.2. By Technique

        13.13.3. By Application

        13.13.4. By Products & Services

        13.13.5. By End-user

        13.13.6. By Country/Sub-region

14. Asia Pacific Transplant Diagnostics Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Screening, 2017 to 2031

        14.2.1. Pre-transplant Diagnostics

        14.2.2. Post-transplant Diagnostics

    14.3. Market Attractiveness, by Screening

    14.4. Market Value Forecast, by Technique, 2017 to 2031

        14.4.1. Molecular Assay

        14.4.2. Non-molecular Assay

    14.5. Market Attractiveness, by Technique

    14.6. Market Value Forecast, by Application, 2017 to 2031

        14.6.1. Solid Organ Transplantation

            14.6.1.1. Kidney

            14.6.1.2. Liver

            14.6.1.3. Heart

            14.6.1.4. Lungs

            14.6.1.5. Pancreas

            14.6.1.6. Small Bowel

        14.6.2. Stem Cell Transplantation

    14.7. Market Attractiveness, by Application

    14.8. Market Value Forecast, by Products & Services, 2017 to 2031

        14.8.1. Reagents & Consumables

        14.8.2. Instruments

        14.8.3. Software & Services

    14.9. Market Attractiveness, by Products & Services

    14.10. Market Value Forecast, by End-user, 2017 to 2031

        14.10.1. Hospitals & Transplant Centers

        14.10.2. Research Laboratories

        14.10.3. Others

    14.11. Market Attractiveness, by End-user

    14.12. Market Value Forecast, by Country/Sub-region, 2017 to 2031

        14.12.1. China

        14.12.2. Japan

        14.12.3. India

        14.12.4. Australia & New Zealand

        14.12.5. Rest of Asia Pacific

    14.13. Market Attractiveness Analysis

        14.13.1. By Screening

        14.13.2. By Technique

        14.13.3. By Application

        14.13.4. By Products & Services

        14.13.5. By End-user

        14.13.6. By Country/Sub-region

15. Latin America Transplant Diagnostics Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Market Value Forecast, by Screening, 2017 to 2031

        15.2.1. Pre-transplant Diagnostics

        15.2.2. Post-transplant Diagnostics

    15.3. Market Attractiveness, by Screening

    15.4. Market Value Forecast, by Technique, 2017 to 2031

        15.4.1. Molecular Assay

        15.4.2. Non-molecular Assay

    15.5. Market Attractiveness, by Technique

    15.6. Market Value Forecast, by Application, 2017 to 2031

        15.6.1. Solid Organ Transplantation

            15.6.1.1. Kidney

            15.6.1.2. Liver

            15.6.1.3. Heart

            15.6.1.4. Lungs

            15.6.1.5. Pancreas

            15.6.1.6. Small Bowel

        15.6.2. Stem Cell Transplantation

    15.7. Stem Cell Transplantation Market Attractiveness, by Application

    15.8. Market Value Forecast, by Products & Services, 2017 to 2031

        15.8.1. Reagents & Consumables

        15.8.2. Instruments

        15.8.3. Software & Services

    15.9. Market Attractiveness, by Products & Services

    15.10. Market Value Forecast, by End-user, 2017 to 2031

        15.10.1. Hospitals & Transplant Centers

        15.10.2. Research Laboratories

        15.10.3. Others

    15.11. Market Attractiveness, by End-user

    15.12. Market Value Forecast, by Country/Sub-region, 2017 to 2031

        15.12.1. Brazil

        15.12.2. Mexico

        15.12.3. Rest of Latin America

    15.13. Market Attractiveness Analysis

        15.13.1. By Screening

        15.13.2. By Technique

        15.13.3. By Application

        15.13.4. By Products & Services

        15.13.5. By End-user

        15.13.6. By Country/Sub-region

16. Middle East & Africa Transplant Diagnostics Market Analysis and Forecast

    16.1. Introduction

        16.1.1. Key Findings

    16.2. Market Value Forecast, by Screening, 2017 to 2031

        16.2.1. Pre-transplant Diagnostics

        16.2.2. Post-transplant Diagnostics

    16.3. Market Attractiveness, by Screening

    16.4. Market Value Forecast, by Technique, 2017 to 2031

        16.4.1. Molecular Assay

        16.4.2. Non-molecular Assay

    16.5. Market Attractiveness, by Technique

    16.6. Market Value Forecast, by Application, 2017 to 2031

        16.6.1. Solid Organ Transplantation

            16.6.1.1. Kidney

            16.6.1.2. Liver

            16.6.1.3. Heart

            16.6.1.4. Lungs

            16.6.1.5. Pancreas

            16.6.1.6. Small Bowel

        16.6.2. Stem Cell Transplantation

    16.7. Market Attractiveness, by Application

    16.8. Market Value Forecast, by Products & Services, 2017 to 2031

        16.8.1. Reagents & Consumables

        16.8.2. Instruments

        16.8.3. Software & Services

    16.9. Market Attractiveness, by Products & Services

    16.10. Market Value Forecast, by End-user, 2017 to 2031

        16.10.1. Hospitals & Transplant Centers

        16.10.2. Research Laboratories

        16.10.3. Others

    16.11. Market Attractiveness, by End-user

    16.12. Market Value Forecast, by Country/Sub-region, 2017 to 2031

        16.12.1. GCC Countries

        16.12.2. South Africa

        16.12.3. Rest of Middle East & Africa

    16.13. Market Attractiveness Analysis

        16.13.1. By Screening

        16.13.2. By Technique

        16.13.3. By Application

        16.13.4. By Products & Services

        16.13.5. By End-user

        16.13.6. By Country/Sub-region

17. Competition Landscape

    17.1. Market Player – Competition Matrix (By Tier and Size of Companies)

    17.2. Market Share Analysis, by Company (2022)

    17.3. Company Profiles

        17.3.1. Bio-Rad laboratories, Inc.

            17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.1.2. Product Portfolio

            17.3.1.3. Financial Overview

            17.3.1.4. SWOT Analysis

            17.3.1.5. Strategic Overview

        17.3.2. Qiagen N.V.

            17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.2.2. Product Portfolio

            17.3.2.3. Financial Overview

            17.3.2.4. SWOT Analysis

            17.3.2.5. Strategic Overview

        17.3.3. F. Hoffmann-La Roche AG

            17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.3.2. Product Portfolio

            17.3.3.3. Financial Overview

            17.3.3.4. SWOT Analysis

            17.3.3.5. Strategic Overview

        17.3.4. Thermo Fisher Scientific, Inc.

            17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.4.2. Product Portfolio

            17.3.4.3. Financial Overview

            17.3.4.4. SWOT Analysis

            17.3.4.5. Strategic Overview

        17.3.5. Becton, Dickinson and Company

            17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.5.2. Product Portfolio

            17.3.5.3. Financial Overview

            17.3.5.4. SWOT Analysis

            17.3.5.5. Strategic Overview

        17.3.6. Ortho Clinical Diagnostics

            17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.6.2. Product Portfolio

            17.3.6.3. Financial Overview

            17.3.6.4. SWOT Analysis

            17.3.6.5. Strategic Overview

        17.3.7. Immucor, Inc.

            17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.7.2. Product Portfolio

            17.3.7.3. Financial Overview

            17.3.7.4. SWOT Analysis

            17.3.7.5. Strategic Overview

        17.3.8. Illumina, Inc.

            17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.8.2. Product Portfolio

            17.3.8.3. Financial Overview

            17.3.8.4. SWOT Analysis

            17.3.8.5. Strategic Overview

        17.3.9. Siemens Healthineers (Siemens AG)

            17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.9.2. Product Portfolio

            17.3.9.3. Financial Overview

            17.3.9.4. SWOT Analysis

            17.3.9.5. Strategic Overview

        17.3.10. Agilent Technologies

            17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.10.2. Product Portfolio

            17.3.10.3. Financial Overview

            17.3.10.4. SWOT Analysis

            17.3.10.5. Strategic Overview

List of Tables

Table 01: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017 to 2031

Table 02: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017 to 2031

Table 03: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017 to 2031

Table 04: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017 to 2031

Table 05: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017 to 2031

Table 06: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017 to 2031

Table 07: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017 to 2031

Table 08: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017 to 2031

Table 09: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017 to 2031

Table 10: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017 to 2031

Table 11: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017 to 2031

Table 12: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017 to 2031

Table 13: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017 to 2031

Table 14: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017 to 2031

Table 15: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017 to 2031

Table 16: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017 to 2031

Table 17: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017 to 2031

Table 18: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017 to 2031

Table 19: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017 to 2031

Table 20: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017 to 2031

Table 21: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017 to 2031

Table 22: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017 to 2031

Table 23: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017 to 2031

Table 24: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017 to 2031

Table 25: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017 to 2031

Table 26: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017 to 2031

Table 27: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017 to 2031

Table 28: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017 to 2031

Table 29: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017 to 2031

Table 30: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017 to 2031

Table 31: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017 to 2031

Table 32: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017 to 2031

Table 33: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017 to 2031

Table 34: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017 to 2031

Table 35: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017 to 2031

Table 36: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017 to 2031

List of Figures

Figure 01: Global Transplant Diagnostics Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031

Figure 02: Global Transplant Diagnostics Market Revenue (US$ Mn), by Screening, 2022

Figure 03: Global Transplant Diagnostics Market Value Share, by Screening, 2022

Figure 04: Global Transplant Diagnostics Market Revenue (US$ Mn), by Technique, 2022

Figure 05: Global Transplant Diagnostics Market Value Share, by Technique, 2022

Figure 06: Global Transplant Diagnostics Market Revenue (US$ Mn), by Application, 2022

Figure 07: Global Transplant Diagnostics Market Value Share, by Application, 2022

Figure 08: Global Transplant Diagnostics Market Revenue (US$ Mn), by Products & Services, 2022

Figure 09: Global Transplant Diagnostics Market Value Share, by Products & Services, 2022

Figure 10: Global Transplant Diagnostics Market Revenue (US$ Mn), by End-user, 2022

Figure 11: Global Transplant Diagnostics Market Value Share, by End-user, 2022

Figure 12: Global Transplant Diagnostics Market Value Share, by Region, 2022

Figure 13: Global Transplant Diagnostics Market Value (US$ Mn) Forecast, 2017 to 2031

Figure 14: Global Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031

Figure 15: Global Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023 to 2031

Figure 16: Global Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031

Figure 17: Global Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023 to 2031

Figure 18: Global Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

Figure 19: Global Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023 to 2031

Figure 20: Global Transplant Diagnostics Market Revenue (US$ Mn), by Products & Services, 2022

Figure 21: Global Transplant Diagnostics Market Value Share, by Products & Services, 2022

Figure 22: Global Transplant Diagnostics Market Revenue (US$ Mn), by End-user, 2022

Figure 23: Global Transplant Diagnostics Market Value Share, by End-user, 2022

Figure 24: Global Transplant Diagnostics Market Value Share Analysis, by Region, 2022 and 2031

Figure 25: Global Transplant Diagnostics Market Attractiveness Analysis, by Region, 2023 to 2031

Figure 26: North America Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017 to 2031

Figure 27: North America Transplant Diagnostics Market Attractiveness Analysis, by Country, 2023 to 2031

Figure 28: North America Transplant Diagnostics Market Value Share Analysis, by Country, 2022 and 2031

Figure 29: North America Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031

Figure 30: North America Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031

Figure 31: North America Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

Figure 32: North America Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031

Figure 33: North America Transplant Diagnostics Market Value Share Analysis, by End-user, 2023 and 2031

Figure 34: North America Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023 to 2031

Figure 35: North America Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023 to 2031

Figure 36: North America Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023 to 2031

Figure 37: North America Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023 to 2031

Figure 38: North America Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023 to 2031

Figure 39: Europe Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017 to 2031

Figure 40: Europe Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023 to 2031

Figure 41: Europe Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 42: Europe Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031

Figure 43: Europe Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031

Figure 44: Europe Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

Figure 45: Europe Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031

Figure 46: Europe Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031

Figure 47: Europe Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023 to 2031

Figure 48: Europe Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023 to 2031

Figure 49: Europe Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023 to 2031

Figure 50: Europe Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023 to 2031

Figure 51: Europe Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023 to 2031

Figure 52: Asia Pacific Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017 to 2031

Figure 53: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023 to 2031

Figure 54: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 55: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031

Figure 56: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031

Figure 57: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

Figure 58: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031

Figure 59: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031

Figure 60: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023 to 2031

Figure 61: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023 to 2031

Figure 62: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023 to 2031

Figure 63: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023 to 2031

Figure 64: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023 to 2031

Figure 65: Latin America Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017 to 2031

Figure 66: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023 to 2031

Figure 67: Latin America Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 68: Latin America Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031

Figure 69: Latin America Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031

Figure 70: Latin America Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

Figure 71: Latin America Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031

Figure 72: Latin America Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031

Figure 73: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023 to 2031

Figure 74: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023 to 2031

Figure 75: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023 to 2031

Figure 76: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023 to 2031

Figure 77: Latin America Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023 to 2031

Figure 78: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017 to 2031

Figure 79: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023 to 2031

Figure 80: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 81: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031

Figure 82: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031

Figure 83: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

Figure 84: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031

Figure 85: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031

Figure 86: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023 to 2031

Figure 87: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023 to 2031

Figure 88: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023 to 2031

Figure 89: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023 to 2031

Figure 90: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023 to 2031

Copyright © Transparency Market Research, Inc. All Rights reserved